SCHEMBL6038197

SCHEMBL6038197

COc1ccc(NS(=O)(=O)c2ccc(C=CCN3C(=O)c4ccccc4C3=O)cc2)cc1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 7/20 0.56
HDAC4 P56524 4/20 0.56
LMNA P02545 3/20 0.52
HTT P42858 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
RORC P51449 1/20 0.48
ALOX15 P16050 1/20 0.48
MAPK1 P28482 1/20 0.48
HDAC3 O15379 2/20 0.48
HDAC7 Q8WUI4 2/20 0.48
HDAC2 Q92769 2/20 0.48
HDAC10 Q969S8 2/20 0.48
HDAC11 Q96DB2 2/20 0.48
HDAC8 Q9BY41 2/20 0.48
HDAC6 Q9UBN7 2/20 0.48
HDAC9 Q9UKV0 2/20 0.48
HDAC5 Q9UQL6 2/20 0.48
CA12 O43570 1/20 0.47
CA9 Q16790 1/20 0.47
HTR6 P50406 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6038193 1.00 HDAC1 (0.56) HDAC1HDAC4LMNAHTTSMN1; SMN2
SCHEMBL6038059 0.86 HDAC1 (0.52) HDAC1HDAC4LMNAHTTSMN1; SMN2
SCHEMBL6038061 0.86 HDAC1 (0.52) HDAC1HDAC4LMNAHTTSMN1; SMN2
SCHEMBL6037922 0.85 HDAC1 (0.60) HDAC1HDAC4LMNAHTTSMN1; SMN2
SCHEMBL6037919 0.85 HDAC1 (0.60) HDAC1HDAC4LMNAHTTSMN1; SMN2
SCHEMBL6038125 0.81 LMNA (0.55) HDAC1LMNAHTTSMN1; SMN2RORC
SCHEMBL4569196 0.76 HDAC1 (0.71) HDAC1HDAC4LMNAHTTSMN1; SMN2
SCHEMBL399122 0.74 LMNA (0.77) HDAC1HDAC4LMNAHTTSMN1; SMN2
SCHEMBL5622158 0.73 HDAC1 (0.80) HDAC1HDAC4LMNAHTTSMN1; SMN2
SCHEMBL8249933 0.73 HDAC1 (0.80) HDAC1HDAC4LMNAHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060264415-A1 Inhibitors of histone deacetylase METHYLGENE INC. 2006-11-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060264415-A1 Inhibitors of histone deacetylase HDAC1, HDAC3, HDAC11 HDAC1 1/4885HDAC4 7/4885LMNA 851/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.